Literature DB >> 25610319

Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer.

Songul Kaloglu1, Hakan Guraslan2, Ali Ismet Tekirdag1, Hediye Dagdeviren2, Cihan Kaya2.   

Abstract

OBJECTIVE: We aimed to evaluate the predictive value of preoperative thrombocytosis for postoperative tumor stage and tumor grade in patients with endometrial cancer.
MATERIALS AND METHODS: This was a retrospective study carried out in our gynecologic oncology department between January 2000 and December 2011. We reviewed the medical charts of 190 patients diagnosed with endometrial carcinoma and underwent complete staging procedure. The clinicopathologic characteristics of the patients such as; age, gravidity, parity, menopausal status, body mass index, co-morbidities (diabetes, hypertension etc.), stage, grade, histological subtype, depth of myometrial invasion, peritoneal washing cytology and preoperative platelet count were recorded. Endometrioid adenocarcinomas were graded according to the FIGO classification. Blood samples for the measurement of platelet count were obtained 3 days prior to the surgery. Thrombocytosis was defined as a platelet count of 300×10(9)/L. P values less than 0.05 derived from two-tailed tests were considered statistically significant.
RESULTS: The mean age of the study population was 55.4 (range 33-80) years. The mean gravidity was 3.8 (range 0-12) and the mean parity was 3.32 (range 0-11). 108 (56,8%) patients were with body mass index of >30 kg/m(2). The mean platelet count among women was 288, 6±90.7×10(9)/L (range 105-772×10(9)/L). The majority of the patients were with early stage diseases during the surgeries. 170 (89.5%) of the patients had stage I to II disease, and 20 (10.5%) of them had stage III to IV disease. There were no statistical significance between thrombocytosis and age, gravidity, parity, BMI, cancer grade and stage, histological subtype of the tumor, depth of invasion, cervical involvement, intrauterine tumor volume and peritoneal washing cytology.
CONCLUSION: We found that preoperative platelet count was not correlated with the stage or grade of endometrial cancer.

Entities:  

Keywords:  Endometrial cancer; prognosis; thrombocytosis

Year:  2014        PMID: 25610319      PMCID: PMC4299850          DOI: 10.5152/eajm.2014.47

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  20 in total

1.  Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma.

Authors:  K F Tamussino; F Gücer; O Reich; F Moser; E Petru; H S Scholz
Journal:  Int J Gynecol Cancer       Date:  2001 May-Jun       Impact factor: 3.437

2.  Cancer statistics, 1990.

Authors:  E Silverberg; C C Boring; T S Squires
Journal:  CA Cancer J Clin       Date:  1990 Jan-Feb       Impact factor: 508.702

3.  Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.

Authors:  J P Arnoletti; D Albo; M S Granick; M P Solomon; A Castiglioni; V L Rothman; G P Tuszynski
Journal:  Cancer       Date:  1995-09-15       Impact factor: 6.860

4.  Tumor Growth: A Putative Role for Platelets?

Authors: 
Journal:  Oncologist       Date:  1998

5.  Tumor anemia and thrombocytosis in patients with vulvar cancer.

Authors:  L Hefler; K Mayerhofer; B Leibman; A Obermair; A Reinthaller; C Kainz; C Tempfer
Journal:  Tumour Biol       Date:  2000 Sep-Oct

6.  Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population.

Authors:  Constantine Gorelick; Vaagn Andikyan; Mendy Mack; Yi-Chun Lee; Ovadia Abulafia
Journal:  Int J Gynecol Cancer       Date:  2009-11       Impact factor: 3.437

Review 7.  Cancer-related anemia: its causes and characteristics.

Authors:  J L Spivak
Journal:  Semin Oncol       Date:  1994-04       Impact factor: 4.929

8.  The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.

Authors:  Tayfun Gungor; Mine Kanat-Pektas; Ayhan Sucak; Leyla Mollamahmutoglu
Journal:  Arch Gynecol Obstet       Date:  2008-05-10       Impact factor: 2.344

9.  The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.

Authors:  Andrew J Li; Alison C Madden; Ilana Cass; Ronald S Leuchter; Leo D Lagasse; Beth Y Karlan
Journal:  Gynecol Oncol       Date:  2004-01       Impact factor: 5.482

10.  Platelet count predicts prognosis in operable non-small cell lung cancer.

Authors:  Dangfan Yu; Bingjiang Liu; Lizhen Zhang; Kaiqi DU
Journal:  Exp Ther Med       Date:  2013-03-12       Impact factor: 2.447

View more
  4 in total

1.  The clinicopathological and prognostic role of thrombocytosis in patients with cancer: A meta-analysis.

Authors:  Xiaojing Zhang; Zunfu Lv; Hua Yu; Jianqing Zhu
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

2.  Pre-treatment thrombocytosis predicts prognosis of endometrial cancer: A meta-analysis of 11 studies.

Authors:  Qingjian Ye; Zhixi Wu; Tingting Xia; Dong Liu; Yuebo Yang; Hong Tang
Journal:  Exp Ther Med       Date:  2019-11-18       Impact factor: 2.447

3.  Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.

Authors:  Ahmed Abu-Zaid; Mohannad Alsabban; Mohammed Abuzaid; Osama AlOmar; Hany Salem; Ismail A Al-Badawi
Journal:  Ann Saudi Med       Date:  2017 Sep-Oct       Impact factor: 1.526

4.  Prognostic Values of Platelet-Associated Indicators in Resectable Cervical Cancer.

Authors:  Jing-Mei Wang; Ying Wang; Yue-Qing Huang; Han Wang; Jie Zhu; Jian-Ping Shi; Yi-Fan Li; Jing-Jing Wang; Wen-Jie Wang
Journal:  Dose Response       Date:  2019-09-08       Impact factor: 2.658

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.